News

This acquisition would add a once-daily oral H4 receptor antagonist in development for atopic dermatitis (AD), commonly known as eczema, to complement the growing Novartis dermatology portfolio and

The recommendation is for treating NSCLC patients whose tumors have high PD-L1 expression without any EGFR or ALK positive tumor mutations. The CHMP’s positive opinion came through from

The competition watchdog accused the company of breaking competition law by raising the price of hydrocortisone tablets from £0.70 to £88 over an eight-year span. Between 2008 and

Cancer Research UK’s Centre for Drug Development (CDD) will sponsor and fund a Phase Ia and Phase Ib clinical trial for a drug called BT1718, a Bicycle Drug

The deal covers the on-demand supply and distribution of BioQ Pharma’s pre-filled Ropivacaine Readyfusor for post-operative pain management in Europe, excluding France and Germany. Under the terms of

Headquartered in Ahmedabad, India, Claris Injectables has a portfolio of essential generic injectable medicines like anesthesia and analgesics, renal, anti-infectives and critical care in a range of presentations

The compound was well-tolerated, with negligible incidences of nausea and vomiting across all arms of the study. Trends towards weight loss were also observed. “It is remarkable to

The patent details methods used to develop sofosbuvir-based medicines for the treatment of patients with hepatitis C virus (HCV) infection, including Sovaldi and Harvoni. The jury’s verdict upholds patent

The deal includes refinancing of existing Capsugel debt of about $2bn. KKR acquired Capsugel from Pfizer for $2.4bn in 2011. Based in Morristown, New Jersey, Capsugel is engaged